PS-108-NGM, a novel activator of beta-Klotho/FGFR1c: A single dose significantly reduces steatosis (liver fat by MRI-PDFF), inflammation (ALT, AST) and fibrogenic activity (Pro-C3) in NAFLD subjects

Saved in:

Bibliographic Details
Published in	Journal of hepatology Vol. 70; no. 1; pp. e68 - e69
Main Authors	DePaoli, Alex, Bashir, Mustafa, Phung, Van, Yan, Andrew, Ling, Lei, Baxter, Bryan, Tian, Hui
Format	Journal Article
Language	English
Published	Elsevier B.V 01.04.2019
Online Access	Get full text

Loading…

Be the first to leave a comment!